Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects
By Sutapa Barua, S. Mitragotri. Nano Today, 2014
1,087 citations recorded by the source corpus.
Nanoparticles (NPs) have emerged as an effective modality for the treatment of various diseases including cancer, cardiovascular and inflammatory diseases. Various forms of NPs including liposomes, polymer particles, micelles, dendrimers, quantum dots, gold NPs and carbon nanotubes have been synthesized and tested for therapeutic applications. One of the greatest challenges that limit the success of NPs is their ability to reach the therapeutic site at necessary doses while minimizing accumulation at undesired sites. The biodistribution of NPs is determined by body’s biological barriers that manifest in several distinct ways. For intravascular delivery of NPs, the barrier manifests in the form of: (i) immune clearance in the liver and spleen, (ii) permeation across the endothelium into target tissues, (iii) penetration through the tissue interstitium, (iv) endocytosis in target cells, (v) diffusion through cytoplasm and (vi) eventually entry into the nucleus, if required. Certain applications of NPs also rely on delivery through alternate routes including skin and mucosal membranes of the nose, lungs, intestine and vagina. In these cases, the diffusive resistance of these tissues poses a significant barrier to delivery. This review focuses on the current understanding of penetration of NPs through biological barriers. Emphasis is placed on transport barriers and not immunological barriers. The review also discusses design strategies for overcoming the barrier properties.
Subfields: Biomaterials, Molecular Biology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/5680a56586000384bf1991d897fb2e45054f9ce4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Molecular Biology
In Pharmaceutical Science
Citations in the corpus
- Innovative approaches for cancer treatment: current perspectives and new challenges (2019, background): “Passive targeting, however, is difficult to control and can induce multidrug resistance (MDR) [128].”
- Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems (2023, background): “These particles can easily penetrate target cells and accumulate into subcellular structures to modify cellular processes, which may be beneficial in the treatment of lifelong diseases such as diabetes, cancer, and kidney diseases [32].”
- Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties (2018, background): “, mitochondria and nuclei; this may drastically alter cell metabolism and cause DNA lesions, mutations, and cell death [39].”
- Polymeric nanoparticles: Promising platform for drug delivery. (2017, background): “These mandatory addition was for the importance of such data regarding the efficacy and safety of nanoparticles specially the information regarding the accurate particle size range which will affect many pharmacological outcomes like nanoparticles bio-distribution, targeting profile and toxicity pro”